Abstract
Purpose
Results of vitreous surgery alone in patients with diabetic macular edema (Vit group) were compared with results of surgery combined with peeling of the internal limiting membrane (ILM group), and surgery combined with removal of the residual vitreous cortex after its visualization using triamcinolone acetonide (TA) and a postoperative intravitreal TA injection (TA group). Visual acuities after the operation, degree of improvement in visual acuity (VA), and intra- and postoperative complications were evaluated.
Methods
The study included 141 consecutive patients (168 eyes) who could be followed up for at least 12 months after the operation. The Vit group consisted of 66 eyes, the ILM group of 62 eyes, and the TA group of 40 eyes. Patient background factors, and visual acuities 6 and 12 months after operation were evaluated first, and at the final examination, the degree of improvement in VA, the incidences of intra- and postoperative complications, and the incidence of intraocular pressure ≥25 mmHg were studied.
Results
Preoperative VA was compared with the 6- and 12-month postoperative VA and the VA at the final examination. The preoperative to 6 months postoperative improvements and those between the 12-month postoperative and final examination did not differ among the three groups. However, the degree of improvement in VA between 6 and 12 months after the operation was significantly smaller in the TA group than in the other two groups. The incidences of intra- and postoperative complications did not differ among the three groups, but the incidence of intraocular pressure ≥25 mmHg was slightly higher in the TA group.
Conclusion
Surgical results did not differ among the three operative techniques examined in this study.
Similar content being viewed by others
References
Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753–759.
Gandorfer A, Messmer EM, Ulbig MW, et al. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000;20:126–133.
Kumagai K, Ogino N, Furukawa M, et al. Internal limiting membrane peeling in vitreous surgery for diabetic macular edema. Nippon Ganka Gakkai Zassi 2002;106:590–594.
Matsushita S, Naito T, Kojima M, et al. Removal of internal limiting membrane during vitreous surgery for diabetic macular edema. Jpn J Clin Ophthalmol 2004;58:1029–1032.
Senda N, Shibuki H, Katai N, et al. Long term outcome of internal limiting membrane peeling in diabetic macular edema. Jpn J Ophthalmol Surg 2004;17:573–576.
Nakamura H, Hayakawa K, Gaja T, et al. Effect of vitrectomy with internal limiting membrane for diffuse diabetic macular edema. Atarashii Ganka 2005;22:403–406.
Yamamoto T, Hitani K, Sato Y, et al. Vitrectomy for macular edema with and without internal limiting membrane removal. Ophthalmologica 2005;219:206–213.
Kamura Y, Sato Y, Shimada H. Effect of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema. Jpn J Ophthalmol 2005;49:297–300.
Kimura T, Kiryu J, Nishikawa H, et al. Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina 2005;25:454–461.
Mochizuki Y, Hata Y, Enaida H, et al. Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema. Retina 2006;26:143–148.
Aritomi H, Fujikawa A, Iuchi T, et al. Effect of triamcinolone acetonide during vitreous surgery for diabetic macular edema. Jpn J Clin Ophthalmol 2005;59:1341–1344.
Shimonagano Y, Doi N, Noda Y, Uemura A, Sakamoto T. Recurrence of diabetic macular edema after intravitreous injection of triamcinolone following vitrectomy. Jpn J Ophthalmol 2007;51:278–284.
Nakamura A, Shimada Y, Horio N, et al. Vitrectomy for diabetic macular edema with posterior subtenon injection of triamcinolone acetonide. Folia Ophthalmol Jpn 2004;55:958–962.
Kadonosono K, Itoh N, Uchio E, et al. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116–1118.
Peyman GA, Cheema R, Conway MD, et al. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2000;20:554–555.
Sakamoto T, Miyazaki M, Ishibashi T, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Exp Ophthalmol 2002;240:423–429.
Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996;122:258–260.
Yamamoto T, Yamamoto S, Takeuchi S. Pars plana vitrectomy for diabetic macular edema with posterior vitreous detachment. J Eye 2000;17:133–138.
Sato Y, Lee Z, Shimada H. Vitrectomy for diabetic cystoid macular edema. Jpn J Ophthalmol 2007;46:315–322.
Funatsu H, Yamashita H, Makamura S, et al. Vitreous level of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2006;113:294–301.
Stefansson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 1990;31:284–289.
Enaida H, Sakamoto T, Ishibashi T, et al. Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Exp Ophthalmol 2002;240:209–213.
Engelbrecht NE, Freeman J, Sippy BD, et al. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2002;133:89–94.
Ueno S, Kondo M, Piao CH, et al. Selective amplitude reduction of the PhNR after macular hole surgery: ganglion cell damage related to ICG-assisted ILM peeling and gas tamponade. Invest Ophthalmol Vis Sci 2006;47:3545–3549.
Shah GK, Rosenblatt BJ, Smith M. Internal limiting membrane peeling using triamcinolone acetonide: histopathologic confirmation. Am J Ophthalmol 2004;138:656–657.
Kimura H, Kuroda S, Nagata M. Triamcinolone acetonide-assisted peeling of the internal limiting membrane. Am J Ophthalmol 2004;137:172–173.
Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment diabetic macular edema. Am J Ophthalmol 2001;132:425–427.
Martidis A, Duker JS, Baumal C, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920–927.
Kogure A, Ohkoshi K, Kogure S, et al. Intravitreal triamcinolone for diffuse diabetic macular edema. Jpn J Clin Opthalmol 2005;59:845–850.
Jonas JB, Degenring RF, Kamppeter BA, et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 2005;112:593–598.
Nomura Y, Ataka S, Wada S, et al. Early intraocular pressure elevation after intravitreal injection of triamcinolone acetonide in the vitrectomized eye. Atarashii Ganka 2005;22:1285–1288.
Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791–796.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Shiba, T., Kamura, Y., Yagi, F. et al. Comparison of surgical procedures for vitreous surgery in diabetic macular edema. Jpn J Ophthalmol 53, 120–124 (2009). https://doi.org/10.1007/s10384-008-0639-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-008-0639-2